http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015305929-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9e5b5fc2d445bade7e8bcb8222cb594
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-009
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B1-043
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
filingDate 2013-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abd5459da91412831650bdc3e5d4c888
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d4dc834ad76e5966ffb7d294076ccbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e3f133ef499e4f73ebdd3a7add1c749
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9cdb1a8760d7c745a4c82f108b88c3d
publicationDate 2015-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2015305929-A1
titleOfInvention Magnetic contact lenses and methods of treatment and diagnosis using the same
abstract In certain aspects, the invention is directed to magnetic contact lenses that comprise one or more magnets. When worn by a patient, the magnetic contact lenses are configured to generate an intraocular magnetic field of sufficient magnitude and direction to move a magnetic therapeutic and/or diagnostic agent positioned inside the eye to target tissue within the eye. Other aspects of the invention pertain to kits which comprise such magnetic contact lenses as well as one or more additional components, for example, one or more containers of a magnetic diagnostic and/or or therapeutic agent. Further aspects of the invention pertain to methods of treatment, which comprise intraocularly introducing a magnetic therapeutic and/or diagnostic agent into an eye of a patient and fitting a magnetic contact lens to the head of the patient, wherein the magnetic therapeutic and/or diagnostic agent may be introduced to the patient before or after fitting the magnetic contact lens to the head of the patient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11237408-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10505394-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107713998-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10058505-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11672698-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10944290-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11567348-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9937074-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020166776-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017255026-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10327945-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016101043-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015238357-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10959834-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10790700-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10895762-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016118933-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11703695-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018041070-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10845621-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10591750-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11281023-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10644543-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017216628-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11137622-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10838232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10838239-B2
priorityDate 2012-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004086572-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7878650-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID184249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415868024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577454

Total number of triples: 58.